Allstate Corporation’s Globus Medical GMED Stock Holding History

Allstate Corporation’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.13M	Sell	14,289 -989	-6%	-$84.1K	0.01%	703
2026 Q1	$1.32M	Buy	+15,278	New	+$1.37M	0.01%	700
2022 Q1	–	Sell	-7,961	Closed	-$575K	–	658
2021 Q4	$575K	Sell	7,961 -241	-3%	-$17.5K	0.01%	656
2021 Q3	$628K	Sell	8,202 -1,947	-19%	-$156K	0.03%	454
2021 Q2	$787K	Buy	10,149 +960	+10%	+$68.3K	0.03%	377
2021 Q1	$567K	Hold	9,189	–	–	0.02%	505
2020 Q4	$599K	Sell	9,189 -2,204	-19%	-$127K	0.02%	428
2020 Q3	$564K	Sell	11,393 -63	-0.5%	-$3.25K	0.02%	376
2020 Q2	$547K	Hold	11,456	–	–	0.02%	409
2020 Q1	$487K	Buy	11,456 +5,842	+104%	+$289K	0.02%	355
2019 Q4	$331K	Buy	+5,614	New	+$305K	0.01%	517

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Allstate Corporation's GMED Position: Q2 2026 in Review

Allstate Corporation reduced its Globus Medical (GMED) stake by 6.5% in Q2 2026, selling an estimated $84.1K and leaving 14,289 shares worth $1.13M. The position accounts for 0.01% of the portfolio, ranked #703.

Allstate Corporation first reported a position in GMED in Q4 2019 and has held it in 11 quarters since. The position peaked at $1.32M in Q1 2026. 600 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Allstate Corporation held 14,289 shares of Globus Medical worth $1.13M as of Q2 2026.
Allstate Corporation sold 989 Globus Medical shares in Q2 2026, an estimated $84.1K.
Globus Medical made up 0.01% of Allstate Corporation's portfolio in Q2 2026, its #703 holding.
Allstate Corporation first reported a position in Globus Medical in Q4 2019 and has held it in 11 quarters since.
Allstate Corporation's Globus Medical position peaked at $1.32M in Q1 2026.
600 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.